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Fusarium fungi are among the most abundant
fungi that infect crops such as wheat, corn,
and barley (1–3). The presence of Fusarium
fungi in dietary corn has been associated with
elevated incidences of esophageal cancer
among inhabitants of the Transkei region of
South Africa (4), the Henan province of the
People’s Republic of China (5), and the
Pordenone province of Italy (6). These studies
did not ﬁnd an association of fungal contami-
nation with other human cancers (e.g., liver or
kidney). The mycotoxin fumonisin B1 (FB1)
was puriﬁed from cultures of Fusarium verti-
cillioides (= F. moniliforme) isolate MRC 826
as a compound responsible for the induction
of liver cancer in BD IX rats (7–9). 
The role of FB1 as a tumor initiator or
promoter was investigated by Gelderblom
and colleagues (10). Including 1,000 ppm
FB1 in the diet of male BD IX rats for 4
weeks resulted in the formation of hepatocel-
lular necrosis, mitotic figures, karyomegaly,
bile ductile proliferation and fibrosis, and
some necrosis in the proximal convoluted
tubules in the kidney (10). When the diet of
male Fischer 344 (F344) rats included 1,000
ppm FB1 for 26 days, γ-glutamyl trans-
peptidase-positive (GGT+) foci formed in
the livers (11). Subsequent treatment of
the rats with partial hepatectomy and
administration of 2-acetylaminofluorene
and carbon tetrachloride (12,13) resulted in
increased formation of GGT+ foci com-
pared to rats on control diets (11). In
another part of the study (11), male F344
rats were given partial hepatectomies fol-
lowed 18 hr later by treatment with 30
mg/kg diethylnitrosamine, 100 mg/kg FB1,
or vehicle and treated 2 weeks later with the
Solt/Farber protocol. Treatment with
diethylnitrosamine resulted in the forma-
tion of GGT+ foci, whereas including FB1
in the treatment did not result in an
increase in foci formation compared to con-
trols. The intraperitoneal administration of
FB1 either 4 hr before and 18 hr after the
partial hepatectomy or 18 and 24 hr after
the partial hepatectomy did not result in
increased formation of GGT+ foci. These
results suggest that FB1 is not a tumor ini-
tiator. In an initiation/promotion study
(14), male F344 rats were administered 200
mg/kg diethylnitrosamine, then fed diets
containing 0, 10, 50, 100, 250, or 500 ppm
FB1 for 21 days. GGT+ foci were increased
in the livers of the rats that received the
diets containing 250 or 500 ppm FB1. Foci
of the placental form of glutathioneS-trans-
ferase were increased in the rats that
received 100, 250, and 500 ppm FB1.
These results suggest FB1 may act as a
tumor promoter in cancer development.
Research to date indicates that FB1 is not
genotoxic. Including 693 nmole FB1 in bac-
terial mutation assays using Salmonella
typhimurium TA98 and TA100 did not result
in any increased mutagenesis (15). FB1 also
did not induce an SOS response in
Escherichia coli and did not alter the survival
of E. coli strains that differed in DNA repair
when 693 nmole of FB1 was added per plate
(15). Including 250 µM FB1 in primary cul-
tures of male Sprague-Dawley rat hepatocytes
did not induce any DNA repair based on lev-
els of [3H]thymidine incorporated into the
DNA (16). When 140 µM FB1 was added to
primary cultures of female F344 rat hepato-
cytes, there were no changes in the formation
of micronuclei or in the mitotic index (15);
however, increases in chromosomal aberra-
tions were detected at 1.4, 14, and 140 µM
FB1 (15). Therefore, the in vivo initiation/
promotion studies in rats and the in vitro
mutagenicity studies are consistent and sug-
gest that FB1 tumorigenesis involves a
nongenotoxic mechanism.
The carcinogenicity of FB1 was first
demonstrated in a single-dose study in which
FB1 was included at 50 ppm in the diet of
male BD IX rats (9). Five rats on control
diets and ﬁve rats fed 50 ppm FB1 were sacri-
ﬁced at 6, 12, 20, and 26 months and histo-
chemically examined. Liver regenerative
nodules and cholangioﬁbrosis were present in
all rats fed FB1 for 12 months. Liver cirrhosis
and hepatocellular carcinomas were present in
100 and 70% of the rats fed FB1 for 20 and
26 months, respectively. In a subsequent
study, including 25 ppm FB1 in the diet did
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not result in induction of any tumors in male
BD IX rats (10). These results indicate that
FB1 is a complete carcinogen when included
in the diet of male BD IX rats. Additionally,
the dietary level of FB1 required to induce
hepatic tumors in male BD IX rats is between
25 and 50 ppm.
Including FB1 in the diets of male and
female F344/N/Nctr BR rats for 2 years
resulted in formation of renal tubule adeno-
mas and carcinomas in male rats (11,12). The
doses of FB1 ranged from 5 to 150 ppm in
male F344 rats and from 5 to 100 ppm in
female F344 rats. The renal tubule adenomas
and carcinomas were present in male rats
consuming 50 and 150 ppm FB1; there were
no dose-related tumors in the female rats. As
part of this same study, male and female mice
were given diets containing FB1 for 2 years
(11,12). The incidence of hepatocellular ade-
nomas and carcinomas was increased in
female mice fed 50 and 80 ppm FB1, whereas
there were no increases in any tumors in male
mice fed diets containing as high as 150 ppm
FB1. Therefore, results of studies with
F344/N/Nctr BR rats, BD IX rats, and
B6C3F1/Nctr BR mice suggest that FB1 is a
carcinogenic compound when included in the
diet at 50 ppm or higher.
The effects of FB1 in cultures of human
cells in vitro were studied in an attempt to
understand the mechanism of action of FB1
in cell homeostatsis (17). FB1 induced apop-
tosis in primary human keratinocytes in a
dose-dependent manner with a dose as small
as 1 µM (17,18). The apoptosis was charac-
terized by morphologic characteristics, the
presence of fragmented DNA, histochemical
staining techniques to demonstrate disorga-
nization of the nucleus, and electron micro-
scopic examination of cellular structure
(17,18). FB1 also induced apoptosis in nor-
mal human ﬁbroblasts, HepG2 human hepa-
toblastoma cells, and immortalized human
esophageal epithelial cells (17). Induction of
apoptosis or inhibition of the growth of
various cell lines in vitro has also been
described for other cultured mammalian
cells (19–23).
Administration of FB1 to rats or mice
results in induction of hepatocellular and renal
tubule epithelial cell apoptosis. This was ﬁrst
described as single-cell necrosis in livers of rats
and mice treated with FB1 (24,25) and later
confirmed as apoptosis (26). FB1-induced
hepatocellular and renal tubule apoptosis is
reviewed elsewhere in this issue (27). 
Because FB1 is a nongenotoxic carcino-
gen and apoptosis has been suggested as the
principal cellular consequence of exposure to
FB1, we sought to determine whether the
incidence of apoptosis and cell proliferation
in F344/N/Nctr BR rats treated for 28 days
with diets containing FB1 correlated with
the induction of tumors in the 2-year FB1
feeding study.
Materials and Methods
Study Material and Feed
Two different preparations of FB1 were used
in the studies summarized in this article. FB1
was produced by aqueous cultures of F. pro-
liferatum on corn (P.E. Nelson, Pennsylvania
State University, State College, PA, USA).
FB1 was extracted from the lyophilized cul-
ture material using methanol. The FB1 used
in the 28-day feeding study was purified as
free acid to a purity of 92.5% using high-
performance liquid chromatography (HPLC)
(28). The FB1 used in the 2-year feeding
study was purified as ammonium salt to a
purity of > 96% using HPLC. The purity of
the FB1 was established using spectroscopic
and HPLC techniques (28).
Autoclaved powdered NIH-31 rodent
feed (Purina Corp., St. Louis, MO) was the
test diet in the study, and FB1 was added as a
water-based component using a Patterson-
Kelley V-blender (Patterson-Kelley Co., East
Stroudsburg, PA, USA). The FB1 content of
the control diet was below 0.06 ppm feed.
Animals and Housing
Female and male F344/N/Nctr BR rats were
obtained from the breeding colony at the
National Center for Toxicological Research at
4 weeks postpartum. Rats were allocated to
study dose groups in a random manner to
control for weight bias and to reduce sibling
allocation to any dose group. Powdered feed
was available ad libitum in feeders custom
designed for powdered feed, and water was
available ad libitum. Cages and water were
changed twice weekly.
Study Design
Rats (10/dose/sex) were fed diets containing
FB1 for 28 consecutive days. The doses used
in this study were 0, 99, 163, 234, and 484
ppm FB1 (26,28). Rats were fasted overnight
and euthanized by asphyxiation with carbon
dioxide and bled via the orbital sinus before
necropsy. Organ weights were determined;
tissues were fixed in 10% neutral buffered
formalin and processed as described (28). All
tissues were examined in rats that received the
control diets and the highest FB1 dose (484
ppm); livers and kidneys were examined for
all rats in the study.
The design of the 2-year study has been
described previously (28). Rats and mice
were randomly allocated to dose groups, the
study was conducted, and the tissues were
analyzed for tumors in accordance with the
guidelines of the U.S. National Toxicology
Program (29) and U.S. Food and Drug
Administration (30). 
Determination of Cell Cycle Using
Anti-PCNA Immunohistochemical
Methods 
The proportion of cells in S phase was deter-
mined immunohistochemically with minor
modiﬁcation of established methods (31,32).
Paraffin-embedded kidney sections that had
been ﬁxed for 48 hr in 10% neutral buffered
formalin and subjected to heated-citrate anti-
gen retrieval were used. Mouse monoclonal
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Figure 1. Graphic representation of the relative liver
weights of the rats fed diets containing up to 484 ppm
FB1 for 28 days. Data presented are liver weights as per-
cent of total body weight (mean ± standard error, 10 rats
per sex) for female and male rats. Asterisk (*) indicates
the value is significantly different (p < 0.05) from the
value for rats consuming control diets. 
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Figure 2. Incidence of hepatocellular apoptosis was
determined for female and male rats fed FB1 for 28 days.
The incidence of apoptosis was determined morphologi-
cally in hematoxylin-eosin–stained slides of hepatic tis-
sue. There were 10 rats per dose per sex. Asterisk (*)
indicates the value is significantly different (p < 0.05)
from values in control groups.
Figure 3. The incidence of hepatocellular mitosis was
determined for female (   ) and male (  ) rats fed fumonisin
B1 for 28 days. The incidence of hepatocellular mitosis
was determined morphologically in hematoxylin-
eosin–stained slides of hepatic tissue. There were 10
rats per dose per sex. Asterisk (*) indicates the value is
significantly different (p < 0.05) from values in control
groups.
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antiproliferating cellular nuclear antigen
(anti-PCNA) (clone PC 10, Dako Corp.,
Carpenteria, CA) was localized with a biotiny-
lated antimouse second antibody followed by
streptavadin-peroxidase, with diaminobenzi-
dine as chromogen. Nuclei were counter-
stained with hematoxylin. Approximately
2,000 nuclei per kidney cortex were evaluated
using digitized microscopy and proprietary
image-analysis software (Optimas, Media
Cybernetics, Silver Springs, MD) that semi-
automatically tallied the nonblue (brown)
nuclei representing cells in S phase. The results
are reported as the percent of nuclei in S phase.
Statistical Analysis
Comparison of dosed rats with altered para-
meters to rats on the control diets was accom-
plished using either analysis of variance or
Fisher’s exact test (SigmaStat, Jandel
Scientific, San Rafael, CA, USA). Levels of
signiﬁcant differences were tested at the 95%
conﬁdence level (p < 0.05).
Results
Male and female F344 rats were fed diets con-
taining FB1 for 28 days and their body weights
monitored weekly. Female rats fed a diet con-
taining 484 ppm FB1 had body weights 9.8
and 10.5% less than rats on control diets after
3 and 4 weeks, respectively; female rats fed the
diet containing 234 ppm FB1 had body
weights 6.3% less than control rats at 4 weeks.
Male rats fed diets containing 484 ppm FB1
had body weights 13 and 14.7% less than male
rats on control diets after 3 and 4 weeks in the
study, respectively, whereas rats fed other doses
did not have any differences in body weights
from those of control rats.
Several studies have shown that the liver is
a target organ for FB1 toxicity. Liver weights
of female rats were unaffected by inclusion of
FB1 in the diets; however, liver weights of
male rats were decreased in the rats fed diets
containing 484 ppm FB1 (Figure 1).
Histopathologic examination was con-
ducted on livers of the rats fed FB1 for 28 days.
The most predominant lesions noted were
increased incidence of hepatocellular apoptosis
and mitosis. Apoptosis was morphologically
distinguishable as hepatocytes with decreased
cell volume and withdrawal from neighboring
hepatocytes. The apoptotic cells were
eosinophilic with condensed and marginated
nuclei. There was no apparent necrosis in the
livers; however, there was disorganization of
the sinusoidal structure as a result of the apop-
tosis. An in situ hybridization method for
detection of DNA fragments was used to con-
ﬁrm the identiﬁcation of some of the apoptotic
cells [TUNEL (terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling)
assay (28); data not presented]. The incidence
of morphologically distinguishable hepatocel-
lular apoptosis is summarized in Figure 2. The
number of female rats with hepatocellular
apoptosis increased from 0 at 0 ppm, to 2 of
10 rats at 99 ppm, 9 of 10 rats (90%) at 163
ppm, and all 10 of female rats at 234 and 484
ppm FB1. Male rats evidently were less sensi-
tive to the effects of FB1 because hepatocellu-
lar apoptosis was not present in the males fed
0, 99, and 163 ppm FB1 (Figure 2).
Hepatocellular apoptosis was present in all
male rats fed diets 234 and 484 ppm FB1
(Figure 2). The severity of the hepatocellular
apoptosis was graded minimal (1), mild (2),
moderate (3), or marked (4). In the female rat
livers, the median severity of the apoptosis was
1.2, 1.9, and 2.2 for rats receiving 163, 234,
and 484 ppm FB1, respectively. The median
severity of apoptosis in the male rat livers was
1.1 and 2.3 for the rats in the 234- and 484-
ppm dose groups, respectively. 
Induction of hepatocellular apoptosis in
the rats was accompanied by increases in mor-
phologically distinguishable hepatocellular
mitosis; results are shown in Figure 3 as the
percent of rats with increased mitoses.
Hepatocellular mitoses were increased in the
female rats at 163, 234, and 484 ppm FB1 and
were increased in the male rats only at 484
ppm FB1. Induction of both hepatocellular
proliferation (Figure 3) and hepatocellular
apoptosis (Figure 2) occurred at lower doses in
the female rats than in the male rats.
Hepatocyte proliferation was also determined
using an immunohistochemical method for
the detection of PCNA. The percent of hepa-
tocytes in S phase in male rats on the control
diet was 0.007%, and increased to 0.18, 0.29,
and 1.32% at 163, 234, and 484 ppm FB1,
respectively (Figure 4). The percent of hepato-
cytes in S phase of the cell cycle in female rats
was 0.2% in the control group and did not
increase until 234 and 484 ppm FB1, whereas
the percentage of cells in S phase increased to
0.86 and 0.74%, respectively (Figure 4).
The effect of dietary FB1 on the weights
of the kidneys is presented in Figure 5. The
data are expressed as weight of the kidneys
relative to total body weight. Relative kidney
weights were reduced in all the rats that con-
sumed diets containing FB1. Relative weights
of kidneys in male rats fed 484 ppm FB1
were reduced by 19% from the values of
male rats on control diets, whereas relative
kidney weights in female rats fed 484 ppm
FB1 were reduced by 11% compared to those
of controls (Figure 5). 
The most prevalent morphologic changes
in the kidneys of the rats were increased rates
of renal tubular epithelial cell apoptosis in the
cortico-medullary area. Apoptotic renal
tubule epithelial cells were noted by cellular
shrinkage from adjacent cells, eosinophilic
cytoplasm, and chromatin condensation and
margination in the nucleus. Although apop-
totic bodies were not detected, clear morpho-
logic markers of apoptosis were present. The
morphologic diagnosis of apoptosis was con-
ﬁrmed using the TUNEL assay for detecting
fragmented DNA (not shown). Apoptotic
renal tubule epithelial cells were present in
the kidneys of all male rats treated with 99,
163, 234, and 484 ppm FB1 (Figure 6). The
median severity of apoptosis was mild (2.0) in
all kidneys of the male rats. Apoptotic renal
tubule cells were not detected in kidneys of
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 2 | May 2001 311
2.00
1.50
1.00
0.50
0.00
0 100 200 300 400 500
Fumonisin B1 (ppm)
H
e
p
a
t
o
c
y
t
e
s
 
i
n
 
S
 
p
h
a
s
e
 
(
%
)
 
 
 
*
*
*
*
 
 
 
 
 
  *
 
 
  Female rat
Male rat 1.00
0.90
0.80
0.70
0.60
0.50
0 100 200 300 400 500
Fumonisin B1 (ppm)
K
i
d
n
e
y
 
w
e
i
g
h
t
/
b
o
d
y
w
e
i
g
h
t
 
(
×
1
0
0
)
 
 
 
     
       
*
* * * *
* *
*
 
  Female rat
Male rat
Figure 4. The percent of proliferating hepatocytes was
determined using immunohistochemical methods for the
detection of PCNA. Approximately 2,000 cells were evalu-
ated on each slide for the presence of PCNA-positive cells
in S phase. The data are presented as the mean ± stan-
dard error for 10 rats per dose for males and females.
Asterisk (*) indicates the value is signiﬁcantly different (p
< 0.05) from the control value for the same sex.
Figure 5. Graphic representation of the relative kidney
weights of rats fed diets containing up to 484 ppm
fumonisin B1 for 28 days. Data presented are kidney
weights as percent of total body weight (mean ± stan-
dard error, 10 rats per sex) for female rats and male rats.
Asterisk (*) indicates the value is signiﬁcantly different (p
< 0.05) from the value for rats consuming control diets. 
Figure 6. The incidence of renal tubule epithelial cells
apoptosis was determined in female and male rats fed
FB1 for 28 days. The incidence of apoptosis was deter-
mined morphologically in hematoxylin-eosin–stained
slides. There were 10 rats per dose per sex. Asterisk (*)
indicates the value is significantly different (p < 0.05)
from values in control groups.
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female rats fed 99 ppm FB1 but were present
in all kidneys of female rats that received 163,
234, and 484 ppm FB1 (Figure 6). The
median severity of the apoptosis in female rats
increased from 1.0 at 163 and 234 ppm to
2.4 at 484 ppm. These data demonstrate that
renal tubule apoptosis was induced in both
sexes; however, male rats were more respon-
sive than female rats to the induction of renal
tubule apoptosis by dietary FB1.
Renal tubule cell proliferation at the cor-
tico-medullary junction was determined
using immunohistochemical detection of
nuclear PCNA (Figure 7). The number of
renal tubule epithelial cells in S phase was ele-
vated at all doses of FB1 in male rats and
increased in a dose-dependent manner
(Figure 7). In female rat kidneys, the percent-
age of cells in S phase also increased in a dose-
dependent manner at all doses of FB1;
however, induction of proliferation at 99 and
163 ppm FB1 was less in female than in male
rat kidneys (Figure 7).
The incidence of tumors in male and
female F344 rats treated for up to 2 years
with FB1 has been reported (28,33). No liver
tumors were detected in the male and female
F344 rats in the 2-year study; however, renal
tubule adenomas and carcinomas were
induced in male rats fed diets containing 50
and 150 ppm FB1. Relative weights of the rat
livers and kidneys in that study are shown in
Figures 8 and 9. Relative liver weights of the
male rats fed FB1 for 2 years were decreased
at all doses of FB1 (5, 15, 50, and 150 ppm)
compared to relative liver weights in rats
receiving control diets (Figure 8). In contrast,
relative liver weights in female rats were not
affected by inclusion of FB1 in the diets
(Figure 8). Relative kidney weights in the
male rats were decreased in the groups that
received 15, 50, and 150 ppm FB1 for 2 years
(Figure 9). This decrease in relative kidney
weight plateaued at approximately 21% in
male and female rats consuming diets
containing 50–150 ppm FB1 (Figure 9).
Discussion
Inclusion of FB1 in the diets of F344/N/Nctr
BR rats for 2 years resulted in the formation
of renal tubule adenomas and carcinomas in
male but not in female rats (28,33). We
examined kidneys and livers of rats fed diets
containing up to 484 ppm FB1 for 28 days to
determine whether the presence of apoptosis
and proliferation correlated with the inci-
dence of renal tubule epithelial cells tumors
by FB1 in the 2-year feeding study.
Consumption of 234 and 484 ppm FB1
for 28 days decreased the total body weight in
female rats, and to a lesser extent, in male rats
but only at 484 ppm. This toxicity was not
reﬂected in the relative liver weights in male
and female rats; a decrease in relative liver
weight was detected only in male rats fed 484
ppm FB1 (Figure 1). The presence of hepato-
cellular apoptosis in female rats was increased
by 163, 234, and 484 ppm FB1, whereas
higher doses of FB1 were required for induc-
tion of hepatocellular apoptosis in male rats
(Figure 2). This trend of hepatocytes in the
female rat being more sensitive than those in
the male rat to the toxicity of FB1 addition-
ally was reﬂected in the percentage of rats that
had morphologically distinguishable hepato-
cellular mitoses (Figure 3) and hepatocytes in
the S phase of the cell cycle (Figure 4).
In the 2-year tumor study where FB1 was
fed to male and female F344/N/Nctr BR rats
(28,33), relative liver weights in the male rats
were reduced in a dose-dependent manner at
all FB1 doses, whereas relative liver weights in
the female rats were not affected by dietary
FB1 (Figure 8). These doses did not induce
formation of hepatic tumors in F344/N/Nctr
BR rats (28,33). Consequently, a clear role
for hepatocellular apoptosis and proliferation
in rat liver tumor development cannot be
determined from these studies. In contrast,
hepatocellular carcinomas have been reported
in BD IX rats fed 50 ppm FB1 for up to 26
months (9), and similar doses of FB1 have
been shown to induce foci of altered expres-
sion of γ-glutamyl transpeptidase and placen-
tal glutathione S-transferase activity
(11,14,34). Reasons for differences in respon-
siveness of F344/N/Nctr BR and other rats to
the hepatotoxic and hepatocarcinogenic
effects of FB1 remain to be determined.
In contrast to liver, toxicity of dietary FB1
in kidneys is more pronounced in male than
in female F344/N/Nctr BR rats. Reduction
in relative kidney weights was approximately
19% in male rats consuming 484 ppm FB1
compared to relative kidney weights in con-
trol rats (Figure 5). In female rats, this reduc-
tion in relative kidney weight was only 11%
(Figure 5). Reduction in relative kidney
weights paralleled the induction of renal
tubule epithelial cell apoptosis in rats (Figure
6); the incidence of apoptosis was greater in
male rats than in female rats at 99 ppm FB1.
Similiarly, induction of renal tubule prolifera-
tion, most probably a consequence of apopto-
sis, was increased in male rats at 99 and 163
ppm FB1 compared to that in female rats at
the same doses (Figure 7). Induction of renal
tubule epithelial cell proliferation was equiva-
lent in male and female rat kidneys at 234
and 484 ppm FB1 (Figure 7).
Inclusion of FB1 in the diet of rats for 2
years resulted in formation of renal tubule
epithelial cell adenomas and carcinomas in 19
and 31% of male rats fed 50 and 150 ppm,
respectively (28,33). The FB1-dependent
increase in renal tumors was accompanied by
an increased incidence of renal tubule hyper-
plasia in 29 and 17% of male rats fed 50 and
150 ppm FB1, respectively (28). Female rats
did not develop renal tubule hyperplasia, ade-
nomas, or carcinomas in response to inclu-
sion of up to 100 ppm FB1 in the diet
(28,33). Therefore, it appears that a consis-
tent sex difference exists in the response of
rats in the 28-day and 2-year feeding studies,
in which male rats are more sensitive than
female rats to the toxicity (apoptosis) of
Figure 7. The percent of proliferating renal tubule
epithelial cells was determined using immunohistochem-
ical methods for the detection of PCNA. Approximately
2,000 cells at the cortico-medullary junction were evalu-
ated on each slide for presence of PCNA-positive cells in
S phase. The data are presented as the mean ± standard
error for 10 rats/dose for males and females. Asterisk (*)
indicates the value is significantly different (p < 0.05)
from the control value for the same sex. A double-cross
(‡) indicates the values for the males were higher than
the values for the females at that dose.
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Figure 8. Graphic representation of the relative liver
weights of rats fed diets containing 0–150 ppm FB1 for 2
years. The data presented are liver weights as percent
of total body weight (mean ± standard error) for female
rats and male rats. An asterisk (*) indicates the value is
significantly different (p < 0.05) from the value for rats
consuming control diets. 
Figure 9. Graphic representation of the relative right kid-
ney weights of rats fed diets containing 0–150 ppm FB1
for 2 years. The data presented are right kidney weights
as percent of total body weights (mean ± standard error)
for the female rats and male rats. An asterisk (*) indi-
cates the value is significantly different (p < 0.05) from
the value for rats consuming control diets. 
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dietary FB1; however, relative kidney weights
were decreased in the 28-day (Figure 5) and
2-year (Figure 9) feeding studies for both
male and female rats, suggesting that the sex
difference in response to FB1 is not absolute.
The mechanism of development of renal
tubule adenomas and carcinomas in response
to dietary FB1 is not understood at this time.
Induction of apoptosis in rat kidneys has
been documented by several groups using dif-
ferent strains of rats. FB1 is an inhibitor of
ceramide synthase (35–38), an enzyme
involved in the de novo synthesis of sphin-
golipids. Inhibition of this enzyme results in
increased intracellular sphinganine and
decreased intracellular ceramide and complex
sphingolipid levels (17,18,22,39). Alterations
in these bioactive compounds have been
implicated as the mechanism for the induc-
tion of apoptosis in cells in vitro (23,37,40).
It is known that FB1 induces apoptosis in
rat kidney renal tubule epithelial cells; there-
fore, we propose that FB1 induces tumors in
male rat kidneys through induction of com-
pensatory renal tubule epithelial cell hyper-
plasia in response to FB1-induced apoptosis. 
Increased cell proliferation in the induc-
tion of kidney cancer may play a role in the
development of spontaneous and chemical-
induced renal tumors in the Eker rat.
Formation of renal cell carcinomas in the Eker
rat was ﬁrst described as an autosomal domi-
nant trait (41) and involves a mutation in the
Tsc2 gene (42,43). The presence of homozy-
gous mutant Tsc2 genes is embryolethal (44);
however, animals bearing heterozygous Tsc2
genes develop spontaneous renal cell carcino-
mas by 1 year of age (44). The Tsc2 gene
codes for tuberin (45), which regulates the
GTP-ase activity for Rap-1 and rab-5, two
proteins involved in ras signal transduction
(46,47). Inhibition of tuberin expression in
cultured cells resulted in a decreased G1 transit
time, and an induced proliferation of G0-
arrested cells (48). Transgenic insertion of
wild-type Tsc2 into Eker rats resulted in the
elimination of the embryolethality in homo-
zygous animals and reduced the ability of
N-ethyl-N-nitrosourea to induce renal tumors
in heterozygotics (49). Therefore, loss of con-
trol at critical cell cycle checkpoints through
loss of tuberin expression, and the sustained
hyperplasia results in eventual renal tubule
tumor formation in the Eker rat.
Sustained cellular hyperplasia has been
proposed as a model for the induction of
renal cell tumors in rats by chloroform and by
compounds that induce α2µ-globulin accu-
mulation in renal tubule cell lysosomes of
male rats. In the latter case, chemicals that
bind to α2µ-globulin (e.g., D-limonene)
apparently interfere with α2µ-globulin protein
degradation in the lysosomes (50–52). The
modified α2µ-globulin accumulates in the
lysosomes, resulting in cell death (hyaline
droplet nephropathy). This loss of tubule
cells is followed by compensatory cell prolif-
eration in the tubules (53) and eventual for-
mation of renal tumors. In support of the role
of this mechanism of tumor formation, NCI
Black Reiter rats do not produce α2µ-globulin
(54). Compounds that induce renal tumors
in conventional rats through α2µ-globulin
accumulation and hyaline droplet nephropa-
thy do not induce nephropathy or tumors in
the NCI Black Reiter rats (54). The role of
α2µ-globulin nephropathy and sustained pro-
liferation in the induction of renal cell tumors
was substantiated in the mouse where trans-
genic expression of α2µ-globulin in mice
resulted in development of hyaline droplet
nephropathy (55).
Continuous cell proliferation has also
been associated with increased risk for tumor
development in other tissues. Several com-
pounds have been shown to induce urinary
bladder regenerative hyperplasia and eventu-
ally cancer in rodents (56). The apparent
mechanism of action is the formation of
insoluble calculi, and the physical trauma of
the interaction of the calculi with the urinary
bladder epithelium results in cell death, sus-
tained hyperplasia, and eventual tumor for-
mation (56,57). This is the mechanism in the
induction of urinary bladder tumors in male
rats by high doses of sodium saccharin due to
the high concentrations of protein and alka-
linity of the urine (56,58,59).
In conclusion, we believe there is suffi-
cient evidence to support the hypothesis that
sustained renal tubule regeneration in
response to FB1-induced renal tubule epithe-
lial cell apoptosis participates in the develop-
ment of renal tubule tumors in male
F344/N/Nctr BR rats fed FB1. However, the
increased hyperplasia may not be solely
responsible for the induction of the tumors.
The decrease in relative kidney weights
(Figure 5) and the induction of renal tubule
proliferation (Figure 7) in male and female
F344/N/Nctr BR rats and the induction of
renal tubule apoptosis and hyperplasia in
male but not female rats fed FB1 for 2 years
support the hypothesis. It is anticipated that
ongoing studies concerning the role played by
signal transduction pathways in the induction
of apoptosis will shed additional light on the
molecular mechanism of FB1-induced renal
tubule apoptosis and tumor formation in
male rat kidneys.
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